Showing results (1551-1560 of 2,394) with videos related to

Sort By:
Pageof 240
The AAPS Journal|January 21, 2016
Utility of a Bayesian Mathematical Model to Predict the Impact of Immunogenicity on Pharmacokinetics of Therapeutic ProteinsSteven Kathman, Theingi M Thway, Lei Zhou, et al.
The AAPS Journal|February 25, 2016
Establishing the Quantitative Relationship Between Lanreotide Autogel®, Chromogranin A, and Progression-Free Survival in Patients with Nonfunctioning Gastroenteropancreatic Neuroendocrine TumorsNúria Buil-Bruna, Marion Dehez, Amandine Manon, et al.
The AAPS Journal|February 26, 2016
Determination of Cellular Processing Rates for a Trastuzumab-Maytansinoid Antibody-Drug Conjugate (ADC) Highlights Key Parameters for ADC DesignKatie F Maass, Chethana Kulkarni, Alison M Betts, et al.
The AAPS Journal|September 27, 2015
A Bottom-Up Whole-Body Physiologically Based Pharmacokinetic Model to Mechanistically Predict Tissue Distribution and the Rate of Subcutaneous Absorption of Therapeutic ProteinsKatherine L Gill, Iain Gardner, Linzhong Li, et al.
The AAPS Journal|August 26, 2015
2D-Cosy NMR Spectroscopy as a Quantitative Tool in Biological Matrix: Application to CyclodextrinsGilles Dufour, Brigitte Evrard, Pascal de Tullio
The AAPS Journal|September 5, 2015
Pattern Recognition in Pharmacokinetic Data AnalysisJohan Gabrielsson, Bernd Meibohm, Daniel Weiner
The AAPS Journal|January 16, 2015
Inhalation devices and patient interface: human factorsStefan Leiner, David Parkins, Orest Lastow
The AAPS Journal|December 10, 2014
Reference datasets for bioequivalence trials in a two-group parallel designAnders Fuglsang, Helmut Schütz, Detlew Labes
The AAPS Journal|July 26, 2015
Physiologically Based Pharmacokinetic Predictions of Tramadol Exposure Throughout Pediatric Life: an Analysis of the Different Clearance Contributors with Emphasis on CYP2D6 MaturationHuybrecht T'jollyn, Jan Snoeys, An Vermeulen, et al.
The AAPS Journal|January 1, 2015
Workshop report: Crystal City V--quantitative bioanalytical method validation and implementation: the 2013 revised FDA guidanceBrian Booth, Mark E Arnold, Binodh DeSilva, et al.
Pageof 240